Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07035106

I-WEAR: Evaluating Wearables and Health Summaries in ICU Survivors

This pilot study investigates the use of wearable health technology and bi-weekly digital health summaries in patients recovering from intensive care. Many patients experience physical, psychological, and cognitive challenges after an ICU stay, a condition known as Post-Intensive Care Syndrome (PICS). The study aims to evaluate the feasibility and usability of wearable devices-such as smartwatches, blood pressure monitors, and smart scales-for tracking recovery in real-world settings.

Participants will be randomly assigned to one of three groups: standard ICU follow-up care, wearable use only, or wearable use combined with bi-weekly health reports and optional lifestyle consultations. The study will assess participants' quality of life, experience using the technology, and adherence over a 6-month period. Results will inform the future use of digital tools in post-ICU care.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ludwig Boltzmann Institute Digital Health and Patient Safety

Vienna, 1090, Austria

Location status: Recruiting

About this study

I-WEAR is a single-center, non-invasive, randomized feasibility study conducted at the Medical University of Vienna in collaboration with the Ludwig Boltzmann Institute for Digital Health and Patient Safety. The study targets ICU survivors aged 18-65 years with prior ICU stays of ≥48 hours and comorbid diabetes mellitus and/or cardiovascular disease. The goal is to evaluate the feasibility and usability of wearable technologies and digital health reporting to enhance longitudinal care after ICU discharge.

Participants (n=60) are randomized into three groups:

Control group: Standard ICU follow-up care Intervention group 1: Wearables and app (smartwatch, scale, blood pressure monitor) Intervention group 2: Same wearables plus automated bi-weekly health summaries and optional health consultations via Webex Wearable devices include the Garmin Vivosmart 5 (tracking HRV, sleep, stress, and activity), the Garmin Index S2 Smart Scale, and the Garmin Index BPM blood pressure monitor. Data is aggregated via the Fitrockr application and stored in an ISO/IEC 27001-certified cloud environment in compliance with the EU General Data Protection Regulation (GDPR). Participants retain full control over data sharing, and pseudonymized data will be used for research purposes only.

The primary outcomes are feasibility (recruitment, retention, device adherence), and usability (System Usability Scale, qualitative interviews). Secondary outcomes include health-related quality of life measured via SF-36 at enrollment, mid-study (month 3), and study completion (month 6). Descriptive statistics and visualizations will summarize adherence and change trajectories. The study follows CONSORT 2010 guidelines for feasibility studies and includes a decision framework to inform whether to proceed with a definitive trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-65 years at the time of ICU admission
  • ICU stay of at least 48 hours
  • ICU discharge within the last 2 years
  • Comorbidity of diabetes mellitus and/or chronic heart failure/coronary artery disease
  • Written informed consent
  • Access to a home internet connection and smartphone with internet and Bluetooth

Exclusion criteria

  • Presence of a legal guardian
  • No smartphone or internet access
  • No cardiovascular disease/event and/or diabetes
  • Implanted pacemaker or defibrillator
  • Allergies to materials in the wearable devices
  • Transfer from an ICU outside the Medical University of Vienna
  • Homelessness
  • Residence outside of Austria

Treatment and study plan

Wearable Health Monitoring

Device

Participants receive a Garmin Vivosmart 5, Garmin Index S2 Smart Scale, and Garmin Index BPM blood pressure monitor for daily health tracking. Devices sync to the Fitrockr mobile application.

Digital Health Summary and Lifestyle Counseling

Behavioral

Participants receive bi-weekly health summaries via email generated from wearable data and may opt in to monthly video-based lifestyle consultations with trained study staff.

Primary outcomes

  1. Feasibility and Usability of Wearables in ICU Survivors

    Time frame: At 6 months after study enrollment

    Feasibility will be assessed by recruitment rate, retention rate, and adherence to wearable device use. Usability will be assessed using the System Usability Scale (SUS) at the end of the study.

Secondary outcomes

  1. Change in Health-Related Quality of Life (HRQoL)

    Time frame: From enrollment (month 0) to study end (month 6)

    Measured using the SF-36 Version 2 questionnaire at baseline, mid-point (3 months), and end of study (6 months). Group-level and within-subject changes will be analyzed.

  2. Acceptability of Lifestyle Counseling

    Time frame: Over 6-month intervention period

    Number and proportion of participants in intervention group 2 who schedule and attend at least one lifestyle counseling session.

Study contacts

Contact information is provided by the study sponsor or research team.

Akos Tiboldi, Dr.med.univ.

CONTACT

[email protected]

+43 660 7432550

Lisa Lichtenegger, BSc MSc

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Ludwig Boltzmann Gesellschaft

Other

Registry information

Official study title

I-WEAR: From ICU to Recovery - Evaluating the Feasibility and Usability of Bi-Weekly Health Summaries Using Wearables in Patients After Intensive Care Unit Treatment - A Pilot Study

Acronym: I-WEAR

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 24, 2025
Registry last updated
Sep 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.